AMP-AD Knowledge Portal
Sage Bionetworks announces the launch of the Accelerating Medicines Partnership – Alzheimer’s Disease (AMP-AD) Knowledge Portal, a public repository for the 5-year, $130M NIH AMP-AD project. AMP-AD will share data and results developed within this precompetitive AD target discovery and preclinical validation framework.
DREAM ALS Stratification Prize4Life Challenge
We are pleased to announce that the DREAM ALS Stratification Prize4Life Challenge, the first of the DREAM10 Challenges is now open for participation. This Challenge focuses on predicting the progression and survival of ALS patients. The Challenge will leverage the PRO-ACT database of more than 8,000 cases as the Challenge training set, and feature several unpublished datasets that will be used for model validation. To learn more and join this Challenge, click here.
Additional information can be found here.
Sage Bionetworks Launches Two Clinical Studies With Apple’s ResearchKit
March 9 was a big day for Sage Bionetworks and, we hope, an important day for the medical research community. As part of the Apple launch of its ResearchKit platform, Sage Bionetworks announced the launch of two iPhone app-based research studies: Parkinson mPower and Share the Journey.
Our Mission
is to improve the understanding and treatment of human disease through data-driven predictive modeling.
Our Projects
are unified by a common emphasis on leveraging the power of open networks of contributors to solve complex scientific problems.
Our People
work in a variety of disciplines spanning clinical research, computational biology, genomics, and software engineering.
News


